Tangible Shareholders Equity: The value shareholders equity less intangible assets.
XORTX Therapeutics Inc. (XRTX) had Tangible Shareholders Equity of $3.15M for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$0.12M |
|
-- |
|
-- |
|
$0.66M |
|
$-0.66M |
|
$0.78M |
|
$0.12M |
|
$0.12M |
|
$0.12M |
|
$0.12M |
|
$0.12M |
|
$0.12M |
|
$-0.66M |
|
$-0.64M |
|
2.88M |
|
2.88M |
|
$0.23 |
|
$0.23 |
|
| Balance Sheet Financials | |
$2.68M |
|
$0.03M |
|
$1.42M |
|
$4.09M |
|
$0.76M |
|
-- |
|
-- |
|
$0.76M |
|
$3.34M |
|
|
Tangible Shareholders Equity |
$3.15M |
$3.34M |
|
3.48M |
|
| Cash Flow Statement Financials | |
$-3.68M |
|
$-0.04M |
|
$2.78M |
|
$3.45M |
|
$2.47M |
|
$-0.97M |
|
$0.12M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.53 |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.68M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
3.67% |
|
3.89% |
|
2.99% |
|
3.67% |
|
$0.96 |
|
$-1.28 |
|
$-1.28 |
|